DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $204,931 | -0.2% | 826 | -3.5% | 0.06% | +7.7% |
| Q2 2023 | $205,440 | -13.8% | 856 | -9.5% | 0.05% | -14.8% |
| Q1 2023 | $238,430 | -13.9% | 946 | -9.3% | 0.06% | -16.4% |
| Q4 2022 | $276,833 | +25.3% | 1,043 | +16.7% | 0.07% | +19.7% |
| Q3 2022 | $221,000 | -9.1% | 894 | -6.9% | 0.06% | -11.6% |
| Q2 2022 | $243,000 | -11.0% | 960 | +3.3% | 0.07% | -8.0% |
| Q1 2022 | $273,000 | -15.5% | 929 | -5.5% | 0.08% | -31.8% |
| Q4 2021 | $323,000 | +5.9% | 983 | -2.0% | 0.11% | -9.8% |
| Q3 2021 | $305,000 | -8.4% | 1,003 | -7.4% | 0.12% | -9.0% |
| Q2 2021 | $333,000 | +29.6% | 1,083 | -5.2% | 0.13% | +16.5% |
| Q1 2021 | $257,000 | +5.3% | 1,143 | +10.4% | 0.12% | +5.5% |
| Q4 2020 | $244,000 | +4.3% | 1,035 | 0.0% | 0.11% | -19.9% |
| Q3 2020 | $234,000 | +2.2% | 1,035 | -6.8% | 0.14% | -3.5% |
| Q2 2020 | $229,000 | -5.4% | 1,110 | -36.6% | 0.14% | -35.9% |
| Q1 2020 | $242,000 | -23.7% | 1,750 | -10.0% | 0.22% | +13.4% |
| Q4 2019 | $317,000 | -5.4% | 1,945 | -19.6% | 0.19% | -14.2% |
| Q3 2019 | $335,000 | -8.2% | 2,420 | -5.1% | 0.23% | -12.7% |
| Q2 2019 | $365,000 | +8.3% | 2,550 | 0.0% | 0.26% | +0.4% |
| Q1 2019 | $337,000 | +10.1% | 2,550 | -7.3% | 0.26% | +7.5% |
| Q4 2018 | $306,000 | – | 2,750 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |